Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1111JC101----[1] 25 💬
289 Zr-Df-crefmirlimab[1] Crefmirlimab---[2] 13, 25 💬
3Application of T-lymphocytes----[1] 25 💬
4Brincidofovir[1] Brincidofovir[1] Brincidofovir 💬 --[1] 25 💬
5CE-VST01-JC[1] CE-VST01-JC---[1] 25 💬
6Cidofovir[1] Cidofovir[1] Cidofovir 💬 --[1] 25 💬
7Collection of blood and urine----[1] 25 💬
8Crefmirlimab[1] Crefmirlimab---[4] 13, 25, 51, 53 💬
9CYT107----[1] 25 💬
10Cytarabine[1] Cytarabine[2] Cytarabine ,
Cytarabine hydrochloride 💬 		--[8] 11, 13, 14, 25, 34, 49, 60, 65 💬
11Diagnostic Test: Brain MRI----[2] 25, 229 💬
12Didanosine[1] Didanosine[1] Didanosine 💬 --[2] 25, 265 💬
13Emtricitabine[1] Emtricitabine[1] Emtricitabine 💬 --[5] 13, 25, 93, 265, 325 💬
14Enfuvirtide[1] Enfuvirtide[1] Enfuvirtide 💬 --[2] 25, 265 💬
15Filgrastim[1] Filgrastim[1] Filgrastim 💬 [1] CSF3R 💬 [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬[30] 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 63, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
16Immune Checkpoint Inhibitors----[3] 25, 51, 53 💬
17Interferon alfa[1] Interferon alfa[1] Interferon alfa 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[5] 25, 26, 28, 56, 96 💬
18Interferon alfa-2b[2] Interferon alfa,
Interferon alfa-2b		[2] Interferon alfa-2b ,
Interferon alfa 💬 		[2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[2] 25, 26 💬
19Interleukin-7[1] Interleukin-7---[1] 25 💬
20Lariam----[1] 25 💬
21MEFLOQUINE[1] Mefloquine[2] Mefloquine hydrochloride ,
Mefloquine 💬 		--[2] 25, 46 💬
22Methylprednisolone[1] Methylprednisolone[2] Methylprednisolone ,
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[51] 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 111, 127, 145, 162, 164, 211, 222, 223, 224, 271, 283, 284, 285, 296, 300 💬
23NATALIZUMAB[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[5] 13, 15, 25, 46, 96 💬
24Neurological evaluation----[1] 25 💬
25NT-I7----[1] 25 💬
26Pembrolizumab[1] Pembrolizumab[1] Pembrolizumab 💬 [1] PDCD1 💬 [3] Cell adhesion molecule (CAM) interaction, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬[3] 25, 97, 285 💬
27Pembrolizumab, 25 mg/ml solution for intravenous (IV) injection[1] Pembrolizumab[1] Pembrolizumab 💬 [1] PDCD1 💬 [3] Cell adhesion molecule (CAM) interaction, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬[1] 25 💬
28PREDNISOLONE[1] Prednisolone[1] Prednisolone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[48] 3, 11, 13, 14, 18, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 57, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 111, 113, 145, 162, 222, 223, 251, 269, 271, 296, 299, 300 💬
29Probenecid[1] Probenecid[1] Probenecid 💬 --[1] 25 💬
30PyVST----[1] 25 💬
31Recombinant human interleukin-7[1] Interleukin-7---[1] 25 💬
32Spinal tap----[1] 25 💬
33Tenofovir[1] Tenofovir[1] Tenofovir 💬 --[8] 2, 6, 13, 25, 26, 93, 265, 325 💬
34Tenofovir-Emtricitabine[2] Emtricitabine,
Tenofovir		[2] Emtricitabine ,
Tenofovir 💬 		--[1] 25 💬
35TERIFLUNOMIDE[1] Teriflunomide[1] Teriflunomide 💬 [1] DHODH 💬 [1] Pyrimidine metabolism 💬[4] 13, 25, 26, 63 💬
36Topotecan[1] Topotecan[2] Topotecan hydrochloride ,
Topotecan 💬 		--[1] 25 💬
37TYSABRI----[3] 13, 25, 63 💬
38Zalcitabine[1] Zalcitabine[1] Zalcitabine 💬 --[1] 25 💬
39Zidovudine[1] Zidovudine[1] Zidovudine 💬 --[6] 25, 26, 135, 265, 325, 331 💬